拉米夫定
HBeAg
医学
血清转化
乙型肝炎病毒
胃肠病学
强的松
内科学
临床终点
乙型肝炎
外科
病毒学
病毒
临床试验
乙型肝炎表面抗原
作者
Loı̈c Guillevin,Alfred Mahr,Pascal Cohen,C. Larroche,V. Queyrel,V. Loustaud‐Ratti,B. Imbert,Pierre Hausfater,Jean Roudier,P. Bielefeld,P. Petitjean,Didier Smadja,The French Vasculitis Study Group
出处
期刊:
日期:2004-06-03
卷期号:51 (3): 482-487
被引量:137
摘要
The strategy of short-term steroids followed by lamivudine and plasma exchanges effectively led to recovery from HBV-PAN. Because of its oral administration and good safety profile, lamivudine should henceforth be considered the antiviral agent of choice to treat HBV-related PAN.
科研通智能强力驱动
Strongly Powered by AbleSci AI